scispace - formally typeset
J

Jane-Hwei Lee

Researcher at University of Chicago

Publications -  7
Citations -  1791

Jane-Hwei Lee is an academic researcher from University of Chicago. The author has contributed to research in topics: Antibody & Influenza A virus. The author has an hindex of 7, co-authored 7 publications receiving 1606 citations.

Papers
More filters
Journal ArticleDOI

Pandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly cross-reactive memory B cells

TL;DR: B-cell responses in 24 healthy adults immunized with the inactivated 2009 pandemic H1N1 vaccine in 2009 found a rapid, predominantly IgG-producing vaccine-specific plasmablast response, which indicates that antibodies capable of neutralizing most influenza subtypes might indeed be elicited by vaccination.
Journal ArticleDOI

Immune history profoundly affects broadly protective B cell responses to influenza.

TL;DR: An in-depth study of the B cell response to the pandemic 2009 H1N1 vaccine over consecutive years found that people with low titers of preexisting antibodies were more likely to generate a broadly reactive response that targets the more conserved hemagglutinin (HA) stalk region, whereas those with higher levels of preeXisting antibodies responded by targeting the more variable HA head.
Journal ArticleDOI

High abundance of plasma cells secreting transglutaminase 2-specific IgA autoantibodies with limited somatic hypermutation in celiac disease intestinal lesions

TL;DR: It is found that TG2-specific plasma cells are markedly expanded within the duodenal mucosa in individuals with active celiac disease, demonstrating that there is a germline repertoire with high affinity for TG2 that may favor massive generation of autoreactive B cells.
Journal ArticleDOI

Complement-Dependent Lysis of Influenza A Virus-Infected Cells by Broadly Cross-Reactive Human Monoclonal Antibodies

TL;DR: One of the stalk-specific MAbs was subtype cross-reactive to H1 and H2 hemagglutinins, suggesting a role for stalk- specific antibodies in protection against influenza illness, especially by a novel viral subtype which can cause pandemics.